Botanova ads scrutinized
This article was originally published in The Tan Sheet
Executive Summary
The U.K. Medicines and Healthcare products Regulatory Agency upholds three advertising complaints filed last fall against German pharmaceutical company Pascoe Pharmazeutische Praparate GmbH. The complaints allege marketing for Botanova (St. John's wort, passion flower and valerian) misleads consumers. The British Herbal Medicine Association and Schwabe Pharma complained Pascoe ads inappropriately touted Botanova has improved efficacy over other products. The claims violate U.K. ad requirements for traditional herbal medicines. BHMA also complained that Botanova press materials incorrectly said the product is not associated with drug-drug interactions. Pascoe revised the materials and confirmed future marketing material will comply with the U.K. requirements for advertising of registered traditional herbal medicines, according to notices MHRA posted July 17
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.